In terms of locoregional recurrence, risk remains low when patients are treated with RT tailored to their individual risk.

Victoria Rizk, MD, explores genomic assays to refine adjuvant therapy and capture clinical real-world evidence in breast ...

For patients with breast cancer with limited nodal disease after neoadjuvant therapy, axillary radiotherapy (ART) is as ...

In breast cancer patients, radiotherapy may reduce lymphedema (arm swelling) risk compared to surgery after neoadjuvant therapy, offering a less invasive option.

Patients with breast cancer may be able to avoid lymphedema, which can occur after surgery to remove lymph nodes in the ...

Patients with breast cancer may be able to avoid lymphedema, which can occur after surgery to remove lymph nodes in the ...

Patients with breast cancer may be able to avoid lymphoedema, which can occur after surgery to remove lymph nodes in the armpit (the ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their ...

The 3-year axillary RFS rate was 99.2% with axillary lymph node dissection and 98.8% with less-invasive procedures. Less-invasive lymph node procedures are noninferior to axillary lymph node ...